| Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery A Chvatal, R Ambrus, P Party, G Katona, O Jójárt-Laczkovich, ... International journal of pharmaceutics 559, 68-75, 2019 | 70 | 2019 |
| Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation A Alshweiat, G Katona, I Csóka, R Ambrus European Journal of Pharmaceutical Sciences 122, 94-104, 2018 | 56 | 2018 |
| Quality by design based formulation study of meloxicam-loaded polymeric micelles for intranasal administration B Sipos, P Szabó-Révész, I Csóka, E Pallagi, DG Dobó, P Bélteky, ... Pharmaceutics 12 (8), 697, 2020 | 49 | 2020 |
| Synthesis and statistical optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating GLP1 analog designed for oral delivery R Ismail, T Sovány, A Gácsi, R Ambrus, G Katona, N Imre, I Csóka Pharmaceutical Research 36, 1-16, 2019 | 46 | 2019 |
| Encapsulation in polymeric nanoparticles enhances the enzymatic stability and the permeability of the GLP-1 analog, liraglutide, across a culture model of intestinal permeability R Ismail, A Bocsik, G Katona, I Gróf, MA Deli, I Csóka Pharmaceutics 11 (11), 599, 2019 | 43 | 2019 |
| The effect of an optimized wet milling technology on the crystallinity, morphology and dissolution properties of micro-and nanonized meloxicam C Bartos, P Szabó-Révész, C Bartos, G Katona, O Jójárt-Laczkovich, ... Molecules 21 (4), 507, 2016 | 43 | 2016 |
| Development of meloxicam-human serum albumin nanoparticles for nose-to-brain delivery via application of a quality by design approach G Katona, GT Balogh, G Dargó, R Gáspár, Á Márki, E Ducza, ... Pharmaceutics 12 (2), 97, 2020 | 40 | 2020 |
| A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation H Akel, R Ismail, G Katona, F Sabir, R Ambrus, I Csóka International Journal of Pharmaceutics 604, 120724, 2021 | 38 | 2021 |
| Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach C Bartos, E Pallagi, P Szabó-Révész, R Ambrus, G Katona, T Kiss, ... European Journal of Pharmaceutical Sciences 123, 475-483, 2018 | 31 | 2018 |
| Preliminary study of nanonized lamotrigine containing products for nasal powder formulation P Gieszinger, I Csóka, E Pallagi, G Katona, O Jójárt-Laczkovich, ... Drug Design, Development and Therapy, 2453-2466, 2017 | 30 | 2017 |
| Polyvinyl alcohol-based 3D printed tablets: novel insight into the influence of polymer particle size on filament preparation and drug release performance AG Crișan, A Porfire, R Ambrus, G Katona, LM Rus, AS Porav, K Ilyés, ... Pharmaceuticals 14 (5), 418, 2021 | 27 | 2021 |
| Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride K Karimi, G Katona, I Csóka, R Ambrus Journal of Pharmaceutical and Biomedical Analysis 148, 73-79, 2018 | 25 | 2018 |
| Quality-by-design-based development of n-propyl-gallate-loaded hyaluronic-acid-coated liposomes for intranasal administration F Sabir, G Katona, E Pallagi, DG Dobó, H Akel, D Berkesi, Z Kónya, ... Molecules 26 (5), 1429, 2021 | 21 | 2021 |
| Interaction studies between levodopa and different excipients to develop coground binary mixtures for intranasal application T Kiss, T Alapi, G Varga, C Bartos, R Ambrus, P Szabó-Révész, G Katona Journal of Pharmaceutical Sciences 108 (8), 2552-2560, 2019 | 17 | 2019 |
| Preparation and characterization of lamotrigine containing nanocapsules for nasal administration P Gieszinger, NS Csaba, M Garcia-Fuentes, M Prasanna, R Gáspár, ... European Journal of Pharmaceutics and Biopharmaceutics 153, 177-186, 2020 | 16 | 2020 |
| Development of in situ gelling meloxicam-human serum albumin nanoparticle formulation for nose-to-brain application G Katona, B Sipos, M Budai-Szűcs, GT Balogh, S Veszelka, I Gróf, ... Pharmaceutics 13 (5), 646, 2021 | 15 | 2021 |
| A systematic, knowledge space-based proposal on quality by design-driven polymeric micelle development B Sipos, G Katona, I Csóka Pharmaceutics 13 (5), 702, 2021 | 13 | 2021 |
| Study of paracetamol-containing pastilles produced by melt technology G Katona, P Sipos, P Frohberg, J Ulrich, P Szabó-Révész, ... Journal of Thermal Analysis and Calorimetry 123, 2549-2559, 2016 | 11 | 2016 |
| Transformation of meloxicam containing nanosuspension into surfactant-free solid compositions to increase the product stability and drug bioavailability for rapid analgesia C Bartos, R Ambrus, G Katona, T Sovány, R Gáspár, Á Márki, E Ducza, ... Drug Design, Development and Therapy, 4007-4020, 2019 | 10 | 2019 |
| Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction O Jójárt-Laczkovich, G Katona, Z Aigner, P Szabó-Révész European Journal of Pharmaceutical Sciences 95, 145-151, 2016 | 9 | 2016 |
